arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Centene Corporation

CNC Health Care Medical Specialities
$67.50
▲ +0.7% Today
as of Sep 4, 16:47 ET
Last 30 days +4.90% Jul 28 → Sep 04
$60.27 $62.35 $64.43 $66.51 $68.59 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$66.77
High
$68.22
Low
$66.77
Volume
$3M
Avg Vol
$7M
Mkt Cap
$31.7B
P/E (TTM)
—
Beta
—
52w High
$69.36
52w Low
$28.33
Div Yield
—
Shares Out
$494M

Recent Press Releases & News last 60 days · 25 items

mixed ▲ 0 ● 23 ▼ 2
Sep 3 · 14:34 Zacks neutral
How Can Healthcare Inflation Fuel Growth for MRSH, UNH & CNC?
Sep 3 · 02:12 Simply Wall St. neutral
Centene (CNC) Names New CIO As Fair Value Debate Stays In Focus
Sep 2 · 13:46 Zacks neutral
Centene Stock Roars Back 117% in a Year: Is CNC Still a Buy?
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$28
$69
95% of range
Avg surprise (last 2)
-50.3%
Avg reaction (last 2)
-0.1%
50% positive
Latest IV / EM
48%
EM ±2.0% · $68 · Sep 4

Earnings trends

EPS — actual vs estimate Actual Estimate
$-13.50$-9.35$-5.20$-1.04$3.11 Actual $2.04Actual $1.92Actual $0.87Actual $2.16Actual $2.16Actual $1.36Actual $2.90Est $2.36Actual $-0.16Est $0.68Actual $-13.50Actual $3.11Actual $2.19 MarJunSepMarJunSepMar/2025Jun/2025SepMarJun
Revenue vs Net Income Revenue Net income
$-6.6B$9.1B$24.8B$40.5B$56.3B Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $2.19 — — — — financials
Tue Mar 31, 2026Mar 2026 $3.11 — — — — financials
Tue Sep 30, 2025Sep 2025 $-13.50 — — — — financials
Fri Jul 25, 2025Jun/2025 $-0.16 $0.68 -123.5% — +6.1% earnings
Fri Apr 25, 2025Mar/2025 $2.90 $2.36 +22.9% — -6.3% earnings
Mon Sep 30, 2024Sep 2024 $1.36 — — — — financials
Sun Jun 30, 2024Jun 2024 $2.16 — — — — financials
Sun Mar 31, 2024Mar 2024 $2.16 — — — — financials
Sat Sep 30, 2023Sep 2023 $0.87 — — — — financials
Fri Jun 30, 2023Jun 2023 $1.92 — — — — financials
Fri Mar 31, 2023Mar 2023 $2.04 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$53.58B$49.94B—$49.69B$48.74B$46.62B—$42.02B
Cost of revenue$729M$702M—$651M$641M$698M—$692M
Gross profit$4.62B$5.65B—$3.35B$3.02B$5.29B—$4.01B
Operating income$1.20B$1.86B—$-6.95B$-458M$1.53B—$665M
Net income$1.09B$1.54B—$-6.63B$-253M$1.31B—$713M
EPS (diluted)$2.19$3.11—$-13.50$-0.51$2.63—$1.36

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$24.15B$21.26B$17.89B$17.06B$14.51B$14.81B$14.06B$14.58B
Inventory————————
Total current assets$46.69B$44.99B$40.37B$44.06B$40.39B$41.29B$38.00B$37.41B
Total assets$83.01B$81.17B$76.75B$82.09B$86.39B$87.04B$82.44B$82.35B
Long-term debt$16.03B$16.31B$17.35B$17.55B$17.55B$18.31B$18.42B$17.49B
Total liabilities$60.35B$59.65B$56.69B$61.03B$58.89B$59.02B$55.94B$54.94B
Total equity$22.56B$21.50B$19.95B$20.95B$27.49B$28.01B$26.41B$27.40B

Implied volatility — last 90 days

39%59%78%97%116% Jun 07 — IV 50% · EM ±4.7%Jun 08 — IV 51% · EM ±4.2%Jun 09 — IV 49% · EM ±3.6%Jun 10 — IV 59% · EM ±3.5%Jun 11 — IV 62% · EM ±2.6%Jun 15 — IV 45% · EM ±3.3%Jun 16 — IV 59% · EM ±3.5%Jun 17 — IV 82% · EM ±3.4%Jun 19 — IV 43% · EM ±4.7%Jun 22 — IV 51% · EM ±4.3%Jun 23 — IV 46% · EM ±3.4%Jun 24 — IV 51% · EM ±3.0%Jun 25 — IV 63% · EM ±2.6%Jun 29 — IV 60% · EM ±14.3%Jun 30 — IV 62% · EM ±14.4%Jul 01 — IV 63% · EM ±14.5%Jul 02 — IV 61% · EM ±13.6%Jul 03 — IV 62% · EM ±13.6%Jul 06 — IV 63% · EM ±13.2%Jul 07 — IV 62% · EM ±12.8%Jul 08 — IV 62% · EM ±12.4%Jul 09 — IV 61% · EM ±12.0%Jul 10 — IV 62% · EM ±12.0%Jul 13 — IV 66% · EM ±11.8%Jul 14 — IV 67% · EM ±11.5%Jul 15 — IV 63% · EM ±10.5%Jul 16 — IV 66% · EM ±10.6%Jul 17 — IV 65% · EM ±10.2%Jul 20 — IV 73% · EM ±10.1%Jul 21 — IV 75% · EM ±10.0%Jul 22 — IV 86% · EM ±10.8%Jul 24 — IV 85% · EM ±9.4%Jul 27 — IV 117% · EM ±9.8%Jul 28 — IV 62% · EM ±4.5%Jul 29 — IV 72% · EM ±4.3%Jul 30 — IV 62% · EM ±2.6%Aug 03 — IV 50% · EM ±4.2%Aug 04 — IV 53% · EM ±3.8%Aug 05 — IV 54% · EM ±3.2%Aug 06 — IV 57% · EM ±2.4%Aug 10 — IV 44% · EM ±3.6%Aug 11 — IV 53% · EM ±3.8%Aug 12 — IV 49% · EM ±2.9%Aug 13 — IV 47% · EM ±2.0%Aug 17 — IV 42% · EM ±3.5%Aug 18 — IV 44% · EM ±3.2%Aug 19 — IV 43% · EM ±2.5%Aug 20 — IV 42% · EM ±1.8%Aug 24 — IV 44% · EM ±3.7%Aug 25 — IV 45% · EM ±3.3%Aug 26 — IV 53% · EM ±3.1%Aug 27 — IV 58% · EM ±2.4%Aug 31 — IV 48% · EM ±4.0%Sep 01 — IV 40% · EM ±2.9%Sep 02 — IV 42% · EM ±2.5%Sep 03 — IV 48% · EM ±2.0%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in